TaiwanJ Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	609	618	657	1,108	796	759
Market Cap Growth	-3.55%	-5.98%	-40.71%	39.15%	4.93%	-24.34%
Enterprise Value	543	546	609	1,035	726	662
Last Close Price	7.60	7.71	8.20	14.68	10.55	10.05
PS Ratio	-	-	-	48.72	51.86	34.41
PB Ratio	8.59	8.71	6.91	16.55	11.12	4.64
P/TBV Ratio	8.59	8.71	6.91	16.64	11.27	8.75
EV/Sales Ratio	-	-	-	45.50	47.31	30.01
Debt / Equity Ratio	0.03	0.03	0.01	0.02	0.03	0.00
Net Debt / Equity Ratio	-0.93	-0.93	-0.92	-0.86	-0.82	-0.50
Net Debt / EBITDA Ratio	2.71	2.71	3.38	10.89	2.87	9.05
Net Debt / FCF Ratio	2.70	2.70	3.85	25.49	2.64	8.22
Asset Turnover	-	-	-	0.30	0.12	0.13
Quick Ratio	13.77	13.77	16.26	10.36	10.12	12.87
Current Ratio	13.81	13.81	16.31	10.43	10.15	12.90
Return on Equity (ROE)	-29.33%	-29.33%	-27.58%	-8.73%	-78.67%	-7.32%
Return on Assets (ROA)	-17.70%	-17.70%	-19.33%	-5.39%	-48.17%	-3.44%
Return on Invested Capital (ROIC)	-515.90%	-393.78%	-313.44%	-59.94%	-205.73%	-11.84%
Return on Capital Employed (ROCE)	-35.00%	-35.00%	-28.40%	-9.80%	-132.50%	-5.90%
Earnings Yield	-4.00%	-3.94%	-3.40%	-0.55%	-11.61%	-1.64%
FCF Yield	-4.02%	-3.96%	-3.44%	-0.20%	-2.80%	-1.32%
Buyback Yield / Dilution	-4.68%	-4.68%	-1.89%	-	-0.03%	-6.07%